Air Purification for Asthma
Trial Summary
What is the purpose of this trial?
Background: Asthma and obesity are public health crises that have concurrently risen over the past decades, affecting millions of children in the United States and disproportionately affecting low-income minority children in urban areas. The same children at highest risk for asthma and obesity also have greater exposure to indoor and outdoor pollution. Emerging evidence suggests that obesity may confer increased susceptibility to health effects of air pollution. Methods: Aiming to provide causal-level evidence of these observational findings, we propose a home intervention study to 1) test whether targeted reductions of indoor Particulate Matter (PM) concentrations improve the respiratory health of overweight inner-city children with asthma more than that of lean inner-city children with asthma and 2) investigate mediators of susceptibility to indoor PM among overweight versus lean children with asthma. We will accomplish these aims using a 1:1 randomized controlled trial of 200 children with persistent asthma (half normal weight, half overweight) living in Baltimore City. Participants will be randomized to receive either two active air purifiers containing high-efficiency particulate air (HEPA) filters or two sham air purifiers with their filters removed. Implications: If the aforementioned observational findings are confirmed, implications will be directly relevant to the over 170 million children around the world now estimated to be overweight or obese.
Do I need to stop my current medications for this trial?
The trial information does not specify whether you need to stop taking your current medications. It is best to discuss this with the trial coordinators or your doctor.
What data supports the effectiveness of the treatment Active Air Purifier for asthma?
Is air purification safe for humans?
How does the Active Air Purifier treatment for asthma differ from other treatments?
The Active Air Purifier treatment is unique because it focuses on improving indoor air quality by reducing allergens and airborne particles, which can help control asthma symptoms. Unlike traditional asthma medications that are ingested or inhaled, this treatment works by cleaning the air in the patient's environment, potentially reducing the need for medication.35101112
Research Team
Meredith C. McCormack, MD, MHS
Principal Investigator
Johns Hopkins University, Pulmonary and Critical Care Medicine
Eligibility Criteria
This trial is for children aged 8-17 living in Baltimore with persistent asthma, who are either of normal weight or overweight. They must spend most nights at home and have had an asthma exacerbation within the last year. Kids can't join if they're underweight, pregnant, smoke, have serious lung/heart conditions, or live in homes in disrepair.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Home and clinical assessments are conducted before randomization
Treatment
Participants receive either active or placebo air purifiers for 12 weeks
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Active Air Purifier
- Placebo Air Purifier
Find a Clinic Near You
Who Is Running the Clinical Trial?
Johns Hopkins University
Lead Sponsor
National Institute of Environmental Health Sciences (NIEHS)
Collaborator